India to Singapore: Regorafenib Export Trade Route

The India to Singapore Regorafenib corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $17.6K USD. The route is dominated by P.B.P ENTERPRISES PRIVATE LIMITED, which alone accounts for roughly 45% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $2.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 23.6%, placing it at rank #17 among India's top regorafenib export destinations globally.

On the import side, key buyers of Indian regorafenib in Singapore include TO THE ORDER, TO THE ORDER OF THE MANAGER, RADEEP SERVICES and 3 others. TO THE ORDER is the single largest importer with 3 shipments valued at $6.0K USD.

India's regorafenib exports to Singapore are driven primarily by a handful of large-scale manufacturers. P.B.P ENTERPRISES PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Singapore benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — P.B.P ENTERPRISES PRIVATE LIMITED, LEOWIN HEALTHCARE LLP, HEET HEALTHCARE PRIVATE LIMITED — together account for 91% of total trade value on this route. The average shipment value of $2.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical medicine regonat40 mg tab. (regorafenib 40 mg tablets)batch no. 702781 mfg date. 02/23 and harmless pharmaceutical medicine regonat40 mg tab. (regorafenib 40mg tablets)batch no. 702777 mfg date. 02/23 e, suggesting that buyers in Singapore tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER is the largest importer with 3 shipments worth $6.0K USD — representing 34% of all regorafenib imports from India on this route. A total of 6 buyers are active on this corridor.